Phase II study of oxaliplatin reintroduction treated with biweekly S-1 plus oxaliplatin (SOX) in patients with metastatic colorectal cancer.(ORION2)
收藏NIAID Data Ecosystem2026-03-08 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2628628
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Oxaliplatin 85 mg/m2, day1 S-1 80-120 mg/day, day 1-7 or alternate-day every 2 weeks
Primary outcome(s): Progression free survival
Study Design: Single arm Non-randomized
创建时间：
2014-03-15
